Stephens Investment Management Group LLC Has $47.75 Million Stock Holdings in Globus Medical, Inc. (NYSE:GMED)

Stephens Investment Management Group LLC lessened its position in Globus Medical, Inc. (NYSE:GMED - Free Report) by 17.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 577,370 shares of the medical device company's stock after selling 124,490 shares during the period. Stephens Investment Management Group LLC owned about 0.42% of Globus Medical worth $47,754,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in GMED. Empowered Funds LLC purchased a new stake in shares of Globus Medical in the fourth quarter worth $6,404,000. Choreo LLC increased its stake in shares of Globus Medical by 8.4% in the fourth quarter. Choreo LLC now owns 9,284 shares of the medical device company's stock worth $768,000 after purchasing an additional 716 shares in the last quarter. Retirement Systems of Alabama increased its stake in shares of Globus Medical by 107.5% in the fourth quarter. Retirement Systems of Alabama now owns 284,736 shares of the medical device company's stock worth $23,551,000 after purchasing an additional 147,496 shares in the last quarter. Mather Group LLC. increased its stake in shares of Globus Medical by 16.3% in the fourth quarter. Mather Group LLC. now owns 1,356 shares of the medical device company's stock worth $112,000 after purchasing an additional 190 shares in the last quarter. Finally, Berry Wealth Group LP increased its stake in shares of Globus Medical by 5.1% in the fourth quarter. Berry Wealth Group LP now owns 3,409 shares of the medical device company's stock worth $282,000 after purchasing an additional 164 shares in the last quarter. Institutional investors own 95.16% of the company's stock.

Insider Activity at Globus Medical

In related news, SVP Kelly Huller sold 2,500 shares of the firm's stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $87.00, for a total value of $217,500.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Keith W. Pfeil sold 14,167 shares of the firm's stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $88.29, for a total value of $1,250,804.43. The disclosure for this sale can be found here. Insiders own 18.54% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on GMED shares. BTIG Research upped their target price on shares of Globus Medical from $87.00 to $91.00 and gave the stock a "buy" rating in a research report on Thursday, December 12th. Roth Mkm increased their price objective on shares of Globus Medical from $100.00 to $115.00 and gave the company a "buy" rating in a research report on Tuesday, December 17th. StockNews.com lowered shares of Globus Medical from a "buy" rating to a "hold" rating in a research report on Thursday, February 6th. Needham & Company LLC reiterated a "hold" rating on shares of Globus Medical in a research report on Thursday, February 6th. Finally, Piper Sandler increased their price objective on shares of Globus Medical from $80.00 to $100.00 and gave the company an "overweight" rating in a research report on Wednesday, November 6th. Four investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $96.91.

Globus Medical Price Performance

Shares of GMED traded down $0.25 during mid-day trading on Wednesday, reaching $84.03. The company's stock had a trading volume of 913,510 shares, compared to its average volume of 1,295,174. Globus Medical, Inc. has a 12-month low of $49.33 and a 12-month high of $94.93. The stock has a market cap of $11.44 billion, a PE ratio of 125.42, a price-to-earnings-growth ratio of 1.68 and a beta of 1.19. The company's 50 day moving average is $86.62 and its 200 day moving average is $78.40.

Globus Medical Profile

Globus Medical, Inc, a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives.